0.928

1.35% 0.0123

Kronos Bio Inc (KRON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.9157

Aprire:

$0.93

Volume 24 ore:

7,984

Relative Volume:

0.03

Capitalizzazione di mercato:

$56.13M

Reddito:

Utile/perdita netta:

$-112.67M

Rapporto P/E:

-0.4759

EPS:

-1.95

Flusso di cassa netto:

$-79.26M

1 W Prestazione:

-3.33%

1M Prestazione:

-9.02%

6M Prestazione:

-2.31%

1 anno Prestazione:

-18.59%

Intervallo 1D:

$0.9108

$0.9579

Intervallo di 1 settimana:

$0.9031

$0.99

Portata 52W:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Nome

Kronos Bio Inc

Settore

Healthcare (1171)

Industria

Biotechnology (679)

Telefono

(650) 781-5200

Indirizzo

1300 S. EL CAMINO REAL, SAN MATEO

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

KRON's Discussions on Twitter

Confronta KRON con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KRON Kronos Bio Inc	0.934	56.13M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	503.64	130.68B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	665.04	74.97B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	600.36	36.08B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	240.04	31.19B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	257.56	27.56B	3.32B	-860.46M	-1.04B	-8.32

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-14	Downgrade	Piper Sandler	Overweight → Neutral
2024-11-14	Downgrade	TD Cowen	Buy → Hold
2022-09-14	Iniziato	Berenberg	Buy
2021-10-20	Ripresa	Cowen	Outperform
2021-06-24	Iniziato	H.C. Wainwright	Buy
2020-11-03	Iniziato	Cowen	Outperform
2020-11-03	Iniziato	Goldman	Buy
2020-11-03	Iniziato	Jefferies	Buy
2020-11-03	Iniziato	Piper Sandler	Overweight

Mostra tutto

Kronos Bio Inc Borsa (KRON) Ultime notizie

Mar 13, 2025

Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat

Feb 17, 2025

Feb 16, 2025

Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Feb 16, 2025

Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025

Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025

Jan 13, 2025

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 13, 2025

Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat

Jan 01, 2025

Dec 28, 2024

Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia

Dec 28, 2024

Kronos Bio ends partnership with Genentech - Investing.com India

Dec 28, 2024

Dec 27, 2024

Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks

Dec 27, 2024

Dec 06, 2024

Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat

Dec 06, 2024

Dec 03, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024

Dec 02, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Dec 02, 2024

Dec 01, 2024